EKF Diagnostics Holdings plc (LON:EKF – Get Free Report)’s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 27.67 ($0.34) and traded as low as GBX 25.80 ($0.32). EKF Diagnostics shares last traded at GBX 26.35 ($0.32), with a volume of 248,776 shares traded.
EKF Diagnostics Stock Performance
The stock’s 50 day simple moving average is GBX 25.98 and its two-hundred day simple moving average is GBX 27.67. The company has a market cap of £117.11 million, a PE ratio of 2,581.10 and a beta of 0.57. The company has a quick ratio of 1.77, a current ratio of 4.59 and a debt-to-equity ratio of 1.78.
EKF Diagnostics Company Profile
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.
See Also
- Five stocks we like better than EKF Diagnostics
- How to Invest in Blue Chip Stocks
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- Best Stocks Under $5.00
- How Do Stock Buybacks Affect Shareholders?
- Investing in Commodities: What Are They? How to Invest in Them
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
